These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16212268)

  • 1. [Effect of modification of the N-terminal region of molecule on the expression of neotropic effect of semax analogues].
    Glazova NIu; Sebentsova EA; Levitskaia NG; Andreeva LA; Alfeeva LIu; Kamenskiĭ AA; Miasoedov NF
    Izv Akad Nauk Ser Biol; 2005; (4):460-6. PubMed ID: 16212268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of the relationship between analgesic activity and structure of synthetic melanocortin analogs].
    Ivanova DM; Vilenskiĭ DA; Levitskaia NG; Andreeva LA; Alfeeva LIu; Kamenskiĭ AA; Miasoedov NF
    Izv Akad Nauk Ser Biol; 2006; (2):204-10. PubMed ID: 16634438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dependence of long-lasting effects of the ACTH(4-10) analogue semax on the time of its neonatal administration].
    Sebentsova EA; Glazova NIu; Levitskaia NG; Andreeva LA; Alfeeva LIu; Kamenskiĭ AA; Miasoedov NF
    Ross Fiziol Zh Im I M Sechenova; 2005 Feb; 91(2):122-31. PubMed ID: 15835535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nootropic and analgesic effects of Semax following different routes of administration].
    Manchenko DM; Glazova NIu; Levitskaia NG; Andreeva LA; Kamenskiĭ AA; Miasoedov NF
    Ross Fiziol Zh Im I M Sechenova; 2010 Oct; 96(10):1014-23. PubMed ID: 21268834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A nootropic adrenocorticotropin analog 4-10-semax (l5 years experience in its design and study)].
    Asmarin IP; Nezavibat'ko VN; Miasoedov NF; Kamenskiĭ AA; Grivennikov IA; Ponomareva-Stepnaia MA; Andreeva LA; Kaplan AIa; Koshelev VB; Riasina TV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1997; 47(2):420-30. PubMed ID: 9173745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proteolysis of semax analogues with different N-terminal amino acids by aminopeptidases].
    Shevchenko KV; V'iunova TV; Nagaev IIu; Andreeva LA; Alfeeva LIu; Miasoedov NF
    Bioorg Khim; 2011; 37(4):475-82. PubMed ID: 22096989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Opposite Semax influence on conditioning and functional disturbances of avoidance responses in rats].
    Inozemtsev AN; Agapitova AE; Bokieva SB; Glazova NIu; Levitskaia NG; Kamenskiĭ AA; Miasoedov NF
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2013; 63(6):711-8. PubMed ID: 25464761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the N-terminus acetylation of Semax, a synthetic analog of ACTH(4-10), on copper(II) and zinc(II) coordination and biological properties.
    Magrì A; Tabbì G; Giuffrida A; Pappalardo G; Satriano C; Naletova I; Nicoletti VG; Attanasio F
    J Inorg Biochem; 2016 Nov; 164():59-69. PubMed ID: 27586814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of semax and ACTH(5-10) on the impulse activity of central neurons].
    Iasnetsov VV; Pravdivtsev VA; Krylova IN; Kozlov SB; Provornova NA
    Biull Eksp Biol Med; 1998 Mar; 125(3):304-6. PubMed ID: 9606550
    [No Abstract]   [Full Text] [Related]  

  • 10. Semax prevents functional impairments of avoidance response in rats.
    Inozemtsev AN; Agapitova AE; Bokieva SB; Levitskaya NG; Kamenskii AA; Myasoedov NF
    Dokl Biol Sci; 2013 Jan; 448():1-3. PubMed ID: 23479006
    [No Abstract]   [Full Text] [Related]  

  • 11. Semax, synthetic ACTH(4-10) analogue, attenuates behavioural and neurochemical alterations following early-life fluvoxamine exposure in white rats.
    Glazova NY; Manchenko DM; Volodina MA; Merchieva SA; Andreeva LA; Kudrin VS; Myasoedov NF; Levitskaya NG
    Neuropeptides; 2021 Apr; 86():102114. PubMed ID: 33418449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of semax against the background of dopaminergic receptor blockade with haloperidol.
    Sebentsova EA; Levitskaya NG; Andreeva LA; Alfeeva LY; Kamenskii AA; Myasoedov NF
    Bull Exp Biol Med; 2006 Feb; 141(2):170-4. PubMed ID: 16984088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on the neurotropic activity of the products of Semax enzymatic degradation.
    Levitskaya NG; Sebentsova EA; Glazova NYu ; Voskresenskaya OG; Andreeva LA; Alfeeva LYu ; Kamenskii AA; Myasoedov NF
    Dokl Biol Sci; 2000; 372():243-6. PubMed ID: 10944712
    [No Abstract]   [Full Text] [Related]  

  • 14. [Neuroprotective effects of semax in MPTP-induced disturbances of brain dopamine system].
    Levitskaia NG; Sebentsova EA; Andreeva LA; Alfeeva LIu; Kamenskiĭ AA; Miasoedov NF
    Ross Fiziol Zh Im I M Sechenova; 2002 Nov; 88(11):1369-77. PubMed ID: 12587264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nootropic effects of a new analog of the fragment ACTH(5-10)- hexapeptide ACTH(5-7)PGP].
    Glazova NIu; Levitskaia NG; Andreeva LA; Kamenskiĭ AA; Miasoedov NF
    Dokl Akad Nauk; 1999 Jul; 367(1):137-40. PubMed ID: 10505249
    [No Abstract]   [Full Text] [Related]  

  • 16. [Kinetics of Semax penetration into the brain and blood of rats after its intranasal administration].
    Shevchenko KV; Nagaev IIu; Alfeeva LIu; Andreeva LA; Kamenskiĭ AA; Levitskaia NG; Shevchenko VP; Grivennikov IA; Miasoedov NF
    Bioorg Khim; 2006; 32(1):64-70. PubMed ID: 16523722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semax attenuates the influence of neonatal maternal deprivation on the behavior of adolescent white rats.
    Volodina MA; Sebentsova EA; Glazova NY; Levitskaya NG; Andreeva LA; Manchenko DM; Kamensky AA; Myasoedov NF
    Bull Exp Biol Med; 2012 Mar; 152(5):560-3. PubMed ID: 22803132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of proteolysis of Semax analogues with different N-terminal amino acids by carboxypeptidases.
    Shevchenko KV; Nagaev IY; Andreeva LA; Alfeeva LY; Myasoedov NF
    Dokl Biol Sci; 2013 May; 450():146-8. PubMed ID: 23821053
    [No Abstract]   [Full Text] [Related]  

  • 19. [An experimental substantiation for using the "Semax" neuroprotector in the treatment of optic-nerve diseases].
    Sheremet NL; Polunin GS; Ovchinnikov AN; Kamenskiĭ AA; Levitskaia NG; Andreeva LA; Alfeeva LIu; Nagaev IIu
    Vestn Oftalmol; 2004; 120(6):25-7. PubMed ID: 15678666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semax prevents learning and memory inhibition by heavy metals.
    Inozemtsev AN; Bokieva SB; Karpukhina OV; Gumargalieva KZ; Kamensky AA; Myasoedov NF
    Dokl Biol Sci; 2016 May; 468(1):112-4. PubMed ID: 27411820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.